Perceptive Advisors’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Perceptive Advisors’s Portfolio CYAD Stock Details CYAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-75,000	Closed	-$3.14M	–	181
2015 Q3	$3.14M	Hold	75,000	–	–	0.25%	67
2015 Q2	$3.9M	Buy	+75,000	New	+$4.03M	0.24%	76

Other funds holding CYAD

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VIA

Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return

Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Perceptive Advisors's CYAD Position: Q4 2015 in Review

Perceptive Advisors sold out of Celyad Oncology SA American Depositary Shares (CYAD) in Q4 2015, closing a stake of 75,000 shares — an estimated $3.14M sold.

Perceptive Advisors first reported a position in CYAD in Q2 2015 and held it in 2 quarters. The position peaked at $3.9M in Q2 2015. 10 funds tracked by Wall St. Rank hold CYAD as of Q4 2015.

Perceptive Advisors reported no remaining Celyad Oncology SA American Depositary Shares position as of Q4 2015 after selling out during the quarter.
Perceptive Advisors sold 75,000 Celyad Oncology SA American Depositary Shares shares in Q4 2015, an estimated $3.14M.
Perceptive Advisors first reported a position in Celyad Oncology SA American Depositary Shares in Q2 2015 and held it in 2 quarters.
Perceptive Advisors's Celyad Oncology SA American Depositary Shares position peaked at $3.9M in Q2 2015.
10 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q4 2015.

Based on Perceptive Advisors's 13F filing for Q4 2015, filed 16 Feb 2016.